Celldex Therapeutics (CLDX) Debt Ratio (2010 - 2013)

Celldex Therapeutics (CLDX) posted quarterly Debt Ratio of 0.07 for Q1 2013, down 36.86% year-over-year from 0.11 in Q1 2012, and down 22.37% quarter-over-quarter from 0.09 in Q4 2012.

Celldex Therapeutics (CLDX) Debt Ratio (2010 - 2013) Analysis & Trends

Celldex Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.07 for Q1 2013.

  • In Q1 2013, Debt Ratio fell 36.86% year-over-year to 0.07; the TTM figure through Mar 2013 stood at 0.07 (down 36.86% YoY), while the FY2012 annual figure was 0.09, down 41.56% from the prior year.
  • Debt Ratio for Q1 2013 stood at 0.07, down from 0.09 in the prior quarter.
  • The five-year high for Debt Ratio was 0.16 in Q2 2012, with the low at 0.07 in Q1 2013.
  • The 4-year median for Debt Ratio is 0.11 (2012), against an average of 0.12.
  • The sharpest annual moves came in 2011 and 2012: Debt Ratio soared 69.91% in 2011, then tumbled 41.56% in 2012.
  • Celldex Therapeutics' Debt Ratio stood at 0.09 in 2010, then jumped by 69.91% to 0.15 in 2011, then sank by 41.56% to 0.09 in 2012, then slipped by 22.37% to 0.07 in 2013.
  • Business Quant data shows CLDX's Debt Ratio at 0.07 in Q1 2013, 0.09 in Q4 2012, and 0.11 in Q3 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Celldex Therapeutics 3.29 Bn 2.58 Bn -2.57 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2013 0.07
Dec 31, 2012 0.09
Sep 30, 2012 0.11
Jun 30, 2012 0.16
Mar 31, 2012 0.11
Dec 31, 2011 0.15
Sep 30, 2011 0.14
Jun 30, 2011 0.13
Dec 31, 2010 0.09